7459 MEDIPAL HOLDINGS CORPORATION - Financial Results

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

7459

TSE Prime

MEDIPAL HOLDINGS CORPORATION

2,355.5

JPY

-35.0

(-1.46%)

Jan 8, 3:30 pm JST

14.90

USD

Jan 8, 1:30 am EST

Result

PTS

outside of trading hours

ー

Summary Chart Historical News Financial Result

Current Period Guidance

Annual

Result

Guidance History

Growth Rate

Profitability

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Mar, 2021	3,211,125	38,576	52,968	23,926	114.0	42	May 13, 2021	J-GAAP
Mar, 2022	3,290,921	45,624	62,046	29,423	140.1	44	May 13, 2022	J-GAAP
Mar, 2023	3,360,008	48,972	65,122	38,806	184.8	46	May 12, 2023	J-GAAP
Mar, 2024	3,558,732	47,330	64,570	41,474	195.8	60	May 14, 2024	J-GAAP
Mar, 2025 Guidance	3,660,000	50,000	66,000	33,500	161.1	60	May 14, 2024	J-GAAP
YoY	+2.8%	+5.6%	+2.2%	-19.2%	-17.7%

Revision Direction	Revision Date	Revenue	Operating Profit	Ordinary Profit	Net Profit	Revised Dividend	Accounting Standards
Mar, 2020	May 15, 2019	3,242,000	51,000	65,000	35,000	40	J-GAAP
	Jul 31, 2019	3,242,000	51,000	65,000	38,800	40	J-GAAP
	Apr 28, 2020	3,242,000	51,000	65,000	38,800	41	J-GAAP
Results	May 14, 2020	3,253,079	53,109	68,020	37,968	41	J-GAAP
Mar, 2021	May 14, 2020	Available in future release
	Jul 31, 2020
	Oct 30, 2020
Results	May 13, 2021
Mar, 2022	May 13, 2021
	Apr 28, 2022
Results	May 13, 2022
Mar, 2023	May 13, 2022
Results	May 12, 2023
Mar, 2024	May 12, 2023
Results	May 14, 2024
Mar, 2025	May 14, 2024	3,660,000	50,000	66,000	33,500	60	J-GAAP

Fiscal Year	Revenue	YoY	Operating Profit	YoY	Ordinary Profit	YoY	Adj. EPS	YoY
Mar, 2000	272,472	+3.6	Available in future release
Mar, 2001	1,073,015	+293.8
Mar, 2002	1,222,221	+13.9
Mar, 2003	1,274,502	+4.3
Mar, 2004	1,283,925	+0.7
Mar, 2005	1,665,815	+29.7
Mar, 2006	1,921,713	+15.4
Mar, 2007	2,166,762	+12.8
Mar, 2008	2,254,936	+4.1
Mar, 2009	2,463,569	+9.3
Mar, 2010	2,546,029	+3.3
Mar, 2011	2,662,821	+4.6
Mar, 2012	2,750,233	+3.3
Mar, 2013	2,810,959	+2.2
Mar, 2014	2,947,798	+4.9
Mar, 2015	2,872,905	-2.5
Mar, 2016	3,028,187	+5.4
Mar, 2017	3,063,900	+1.2
Mar, 2018	3,146,314	+2.7
Mar, 2019	3,181,928	+1.1
Mar, 2020	3,253,079	+2.2
Mar, 2021	3,211,125	-1.3
Mar, 2022	3,290,921	+2.5
Mar, 2023	3,360,008	+2.1
Mar, 2024	3,558,732	+5.9
Mar, 2025 Guidance	3,660,000	+2.8	50,000	+5.6	66,000	+2.2	161.1	-17.7

Fiscal Year	Revenue	Operating Profit	Operating Profit Margin	ROE	ROA	Total Asset Turnover Ratio	Adj. EPS
Mar, 2023	3,360,008	48,972	1.46	7.11	2.27	1.97	184.8
Mar, 2024	3,558,732	47,330	1.33	7.14	2.36	2.03	195.8
Mar, 2025 Guidance	3,660,000	50,000	1.37	5.42	1.78	1.95	161.1

All-Time High

	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS
Record	3,558,732	53,109	68,020	41,474	195.8
Fiscal Year	Mar, 2024	Mar, 2020	Mar, 2020	Mar, 2024	Mar, 2024

Second Half

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Oct - Mar, 2021	1,647,677	21,346	28,488	10,898	51.9	23	May 13, 2022	J-GAAP
Oct - Mar, 2022	1,674,612	23,429	31,861	21,482	102.3	23	May 12, 2023	J-GAAP
Oct - Mar, 2023	1,779,743	26,699	35,271	24,320	114.8	30	May 14, 2024	J-GAAP
Oct - Mar, 2024 Guidance	1,835,328	22,838	30,920	11,773	56.6	30	Nov 1, 2024	J-GAAP
YoY	+3.1%	-14.5%	-12.3%	-51.6%	-50.7%

Cash Flow

Annual

Fiscal Year	Operating Profit	Fee Cash Flow	Operating Cash Flow	Investing Cash Flow	Financial Cash Flow	Cash & Equivalents	Cash Ratio	Accounting Standards
Mar, 2022	45,624	36,873	61,216	-24,343	-16,471	260,450	15.24	J-GAAP
Mar, 2023	48,972	-23,348	16,146	-39,494	-43,541	193,561	11.32	J-GAAP
Mar, 2024	47,330	54,026	61,843	-7,817	-25,248	228,084	12.68	J-GAAP

Actual Performance and Financial Trends

Accumulated Results 2nd Quarter

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Progress Rate vs. First Half	Announce	Accounting Standards
Apr - Sep, 2022	1,685,396	25,543	33,261	17,324	82.5	51.1	Oct 31, 2022	J-GAAP
Apr - Sep, 2023	1,778,989	20,631	29,299	17,154	80.5	45.4	Nov 2, 2023	J-GAAP
Apr - Sep, 2024	1,824,672	27,162	35,080	21,727	103.9	53.2	Nov 1, 2024	J-GAAP
YoY	+2.6%	+31.7%	+19.7%	+26.7%	+29.2%

Quarterly Results

Result

Growth Rate

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Operating Profit Margin	Announce	Accounting Standards
Oct - Dec, 2022	882,022	11,988	16,647	12,524	59.7	1.4	Feb 1, 2023	J-GAAP
Jan - Mar, 2023	792,590	11,441	15,214	8,958	42.7	1.4	May 12, 2023	J-GAAP
Apr - Jun, 2023	886,737	12,401	16,676	11,188	52.3	1.4	Aug 2, 2023	J-GAAP
Jul - Sep, 2023	892,252	8,230	12,623	5,966	28.0	0.9	Nov 2, 2023	J-GAAP
Oct - Dec, 2023	935,926	16,584	20,941	11,132	52.4	1.8	Feb 5, 2024	J-GAAP
Jan - Mar, 2024	843,817	10,115	14,330	13,188	62.3	1.2	May 14, 2024	J-GAAP
Apr - Jun, 2024	909,317	13,283	16,916	9,008	43.0	1.5	Aug 1, 2024	J-GAAP
Jul - Sep, 2024	915,355	13,879	18,164	12,719	60.9	1.5	Nov 1, 2024	J-GAAP
YoY	+2.6%	+68.6%	+43.9%	+113.2%	+117.4%

Fiscal Year	Revenue	YoY	Operating Profit	YoY	Ordinary Profit	YoY	Adj. EPS	YoY
Oct - Dec, 2019	828,808	-1.3	Available in future release
Jan - Mar, 2020	769,425	+1.3
Apr - Jun, 2020	794,164	-2.1
Jul - Sep, 2020	794,254	-5.9
Oct - Dec, 2020	850,394	+2.6
Jan - Mar, 2021	772,313	+0.4
Apr - Jun, 2021	824,877	+3.9
Jul - Sep, 2021	818,367	+3.0
Oct - Dec, 2021	864,026	+1.6
Jan - Mar, 2022	783,651	+1.5
Apr - Jun, 2022	838,328	+1.6
Jul - Sep, 2022	847,068	+3.5
Oct - Dec, 2022	882,022	+2.1
Jan - Mar, 2023	792,590	+1.1
Apr - Jun, 2023	886,737	+5.8
Jul - Sep, 2023	892,252	+5.3
Oct - Dec, 2023	935,926	+6.1
Jan - Mar, 2024	843,817	+6.5
Apr - Jun, 2024	909,317	+2.5
Jul - Sep, 2024	915,355	+2.6	13,879	+68.6	18,164	+43.9	60.9	+117.5

All-Time High Quarterly Results

	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS
Record	935,926	17,178	21,453	13,188	62.3
Fiscal Year	Dec, 2023	Dec, 2018	Dec, 2018	Mar, 2024	Mar, 2024

Key Balance Sheet Figures

Fiscal Year	BPS	Equity Ratio	Total Asset	Equity	Retained Earnings	Interest-Bearing Debt Ratio	Announce	Accounting Standards
Mar, 2022	2,525.72	31.0	1,709,474	530,305	385,611	0.06	May 13, 2022	J-GAAP
Mar, 2023	2,673.62	32.8	1,709,658	561,357	414,723	ー	May 12, 2023	J-GAAP
Mar, 2024	2,858.57	33.4	1,799,127	600,349	439,315	ー	May 14, 2024	J-GAAP
Apr - Sep, 2024	2,973.97	32.9	1,879,759	618,440	450,677	ー	Nov 1, 2024	J-GAAP

MEDIPAL HOLDINGS CORPORATION(7459) Financial Results